Patient Recruitment: Pre-Screening and Shortlisting Your Ideal Patients

Smit Shah
CTBM

Request a demo specialized to your need.

For years, I've watched brilliant clinical trials stall not because the science was wrong, not because the protocol was flawed but because we couldn't find the right patients fast enough.

I've sat in review meetings where we celebrated 60% enrollment three months behind schedule, as if that was somehow a win. I've seen sponsors burn millions on recruitment campaigns with no real visibility into what actually worked. I've watched site staff manually screen hundreds of paper forms, missing eligible patients simply because the process was too slow and too fragmented. And the worst part? We all knew it was broken. We just accepted it as "normal."

The scale of the problem

Patient recruitment isn't just a hurdle it's the hurdle. More than 86% of clinical trials fail to meet their enrollment timelines, and roughly 80% are delayed or closed because of recruitment problems. That's not a niche statistic it's one of the most consistently cited numbers in the industry, and it hasn't meaningfully improved in a decade. Patient recruitment alone accounts for close to 40% of total study budget, and each day of delay can cost hundreds of thousands of dollars.

But the numbers only tell half the story. The real cost is human.

Here's what keeps me up at night: manual pre-screening misses nearly 30% of eligible patients especially in rare disease and oncology trials, where every single participant matters. Paper-based consent deters nearly 20% of diverse patients because of language barriers or logistical hurdles. For a Phase II biotech trial, every month of delay costs thousands USD, often risking entire funding rounds.

That's not just an operational failure. That's a failure of access, of equity, of our fundamental promise to bring treatments to everyone who needs them.

The silent killer: manual pre-screening

Let me zoom in on one specific problem: pre-screening.

In traditional models, site staff manually review patient records against eligibility criteria combing through paper charts, spreadsheets, and siloed databases. It's tedious, error-prone, and painfully slow.

Here's what that costs you:

  • Time. Manual pre-screening can take 20–25 minutes per patient. Automated tools can reduce that to a fraction of that time.
  • Money. High screen failure rates are expensive — every rejected candidate represents wasted site time and coordinator hours that could have gone to someone who actually qualifies.
  • Missed patients. Inconsistent eligibility checks mean roughly 30% of eligible patients never even get identified.

But here's the thing patients can do this themselves.

When patients complete pre-screening questionnaires online, they self-qualify before ever stepping into a site. The system automatically records their responses, matches them to the nearest recruiting location, and notifies sites instantly when a participant clears pre-screening.

This isn't just convenient. It's transformational and it's the single biggest lever standing between "60% enrolled, three months late" and actually hitting your timeline.

What we built at Cloudbyz

When we designed the Cloudbyz Patient Recruitment platform, we asked one simple question: what if recruitment wasn't the bottleneck? We didn't want to build another point solution that added to the chaos of disconnected systems. We built an end-to-end unified solution that connects every step of the journey.

Study websites that actually work. Every trial needs a public face. We built a centralized study website builder that lets sponsors create landing pages, self-assessment tools, and patient registration flows.

Automated pre-screening  this is where the magic happens. Instead of site staff manually reviewing eligibility criteria against patient records, our platform automates the entire process. Patients answer predefined questions, and the system automatically matches them to the nearest recruiting site. Sites get notified instantly when a participant clears pre-screening. No more missed eligible patients. No more weeks of manual work.

Digital eConsent. Paper-based consent is outdated, inaccessible, and frankly, a barrier to participation. Our eConsent replaces those dense documents with interactive, multimedia-enabled forms patients can complete on their mobile devices. Multilingual support means we're reaching patients in the languages they actually speak.

Participant portal. We built a patient-facing portal that doesn't feel like clinical trial software. Patients can complete pre-screening, access eConsent, view educational materials, receive study updates, and even see their own lab reports. When patients feel informed and empowered, they stay engaged.

Recruitment campaign management and call center integration. Design campaigns with an easy template-based approach, send email blasts, and track effectiveness in real time. For outbound recruitment, we've integrated with tools like Twilio and Amazon Connect to keep patients and volunteers informed at every step.

The human side

Here's what I have learned in this role: technology is the easy part.

The hard part is earning trust. From sponsors who've been burned by overhyped platforms. From sites who've been promised simplicity and delivered complexity. From patients who've been treated as data points rather than people.

That's why we built Cloudbyz the way we did not as a collection of features, but as an integrated system that actually reduces friction. When a site staff member can pre-screen a patient in minutes instead of hours, that's not just efficiency. That's time they can spend with the patient. When a sponsor can see real-time enrollment data without chasing emails from twenty different sites, that's not just visibility. That's peace of mind. And when a patient can complete pre-screening and consent on their phone, in their language, without making a special trip to a site — that's not just convenience. That's respect.

What I'd tell you

If you're a clinical operations leader still wrestling with manual pre-screening, fragmented systems, or recruitment campaigns you can't measure  know that you're not alone. And know that there's a better way.

The platform exists. The data proves it works. The question isn't whether you can fix patient recruitment. It's whether you're ready to stop accepting "good enough" and actually solve the problem.

Because every day we delay, there's a patient waiting. A therapy delayed. A life that could have been changed.

I don't know about you, but I'm not okay with "good enough" anymore.

Ready to transform your patient recruitment? Visit cloudbyz.com to schedule a demo